American Board of Internal Medicine - Cardiovascular Disease
American Board of Internal Medicine - Interventional Cardiology
Education & Training
1995, Harvard University
Medical / Professional School(s)
2000, Johns Hopkins University School of Medicine
2001, Internal Medicine - Massachusetts General Hospital
2003, Internal Medicine - Massachusetts General Hospital
2005, Internal Medicine/Chief Resident - Massachusetts General Hospital
2008, Cardiovascular Disease - Brigham and Women's Hospital
2008, Interventional Cardiology - Brigham and Women's Hospital
2009, Vascular Medicine - Massachusetts General Hospital
2008, Internal Medicine - Brigham and Women's Hospital
Cardiology, Carotid Artery Disease, Claudication, Coronary Artery Disease (CAD), Interventional Cardiology, Peripheral Arterial Disease, Peripheral Vascular Disease and Intervention, Renal Artery Disease, Vascular Medicine, Venous Disease and Thrombosis
Patient Satisfaction Reviews
About Our Survey
At University Hospitals, we believe in providing patients with all the information they need to make educated decisions
about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent
patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians.
We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for
every individual who sees a UH doctor.
There are no comments for this practitioner.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Sahil Parikh, MD did not disclose any Outside Relationships with Industry.